Critical care : the official journal of the Critical Care Forum
-
Randomized Controlled Trial Multicenter Study Comparative Study
Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study.
Inadequate initial treatment and delayed hemodynamic stabilization (HDS) may be associated with increased risk of death in severe sepsis patients. ⋯ NCT00464204.